Seattle Children's Research Institute

Running trials

• Recruiting

  Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)

  NCT07817875· Phase 3· Eli Lilly and Company· Source

• Recruiting

  A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

  NCT07282613· Phase 3· Novo Nordisk A/S· Source

• Recruiting

  A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)

  NCT06760546· Phase 3· Rhythm Pharmaceuticals, Inc.· Source

• Recruiting

  A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

  NCT06672549· Phase 3· Eli Lilly and Company· Source

• Recruiting

  RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

  NCT06154252· Phase 2/3· Cabaletta Bio· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity3 recruiting
• Dermatomyositis and polymyositis (myositis)1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Completed

  Open-Label Extension Study of Setmelanotide

  NCT06596135· Phase 3· Rhythm Pharmaceuticals, Inc.· Source

• Terminated

  A Study Evaluating the Efficacy and Safety of IV L-Citrulline for the Prevention of Clinical Sequelae of Acute Lung Injury Induced by Cardiopulmonary Bypass in Pediatric Patients Undergoing Surgery for Congenital Heart Defects

  NCT05253209· Phase 3· Asklepion Pharmaceuticals, LLC· Source

• Completed

  Community-Based Care for Minority Adolescents With ADHD: Improving Fidelity With Machine Learning-Assisted Supervision and Fidelity Feedback.

  NCT05135065· Seattle Children's Hospital· Source

• Completed

  Trial to Investigate the Safety and Efficacy of Cannabidiol Oral Solution (GWP42003-P; CBD-OS) in Children and Adolescents With Autism Spectrum Disorder

  NCT04745026· Phase 2· Jazz Pharmaceuticals· Source

• Terminated

  9-ING-41 in Pediatric Patients With Refractory Malignancies.

  NCT04239092· Phase 1· Actuate Therapeutics Inc.· Source

• Completed

  Long Term Extension Trial of Setmelanotide

  NCT03651765· Phase 2/3· Rhythm Pharmaceuticals, Inc.· Source

• Completed

  A Study of Multiple Doses of Nusinersen (ISIS 396443) Delivered to Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy

  NCT02386553· Phase 2· Biogen· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Cystic fibrosis38 works · 0 trials
• Childhood cancers12 works · 1 trial
• Down syndrome9 works · 0 trials
• Mitochondrial disease4 works · 0 trials